FI915677A0 - Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen. - Google Patents

Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.

Info

Publication number
FI915677A0
FI915677A0 FI915677A FI915677A FI915677A0 FI 915677 A0 FI915677 A0 FI 915677A0 FI 915677 A FI915677 A FI 915677A FI 915677 A FI915677 A FI 915677A FI 915677 A0 FI915677 A0 FI 915677A0
Authority
FI
Finland
Prior art keywords
tarmkanalen
patologiska
kataboliska
processer
foerfarande foer
Prior art date
Application number
FI915677A
Other languages
English (en)
Finnish (fi)
Inventor
Robert J Smith
Douglas W Wilmore
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI915677(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of FI915677A0 publication Critical patent/FI915677A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Looms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI915677A 1989-06-02 1991-12-02 Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen. FI915677A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02
PCT/US1990/003095 WO1990014823A1 (fr) 1989-06-02 1990-06-04 Procede pour traiter des processus pathologiques cataboliques lies a l'intestin, ainsi que l'insuffisance des defenses d'un hote

Publications (1)

Publication Number Publication Date
FI915677A0 true FI915677A0 (fi) 1991-12-02

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915677A FI915677A0 (fi) 1989-06-02 1991-12-02 Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.

Country Status (16)

Country Link
EP (1) EP0401056B2 (fr)
JP (4) JP3068644B2 (fr)
KR (1) KR0178799B1 (fr)
AT (1) ATE160089T1 (fr)
AU (1) AU641403B2 (fr)
DE (1) DE69031694T3 (fr)
DK (1) DK0401056T4 (fr)
ES (1) ES2111529T5 (fr)
FI (1) FI915677A0 (fr)
GR (1) GR3025678T3 (fr)
HU (1) HU220214B (fr)
IL (1) IL94549A (fr)
NO (1) NO914730D0 (fr)
PT (1) PT94223B (fr)
WO (1) WO1990014823A1 (fr)
ZA (1) ZA904151B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
EP1362587A1 (fr) 1994-01-11 2003-11-19 Stichting Zofia Utilisation de glutamine dans le traitement de taux plasmatiques de l'arginine bas chez l' animal ou chez l' homme
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
EP1675480B1 (fr) * 2003-10-16 2018-06-13 Nestec S.A. Composition nutritionnelle contre les effets secondaires de la chimiotherapie ou de la radiotherapie
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
JP5580050B2 (ja) * 2006-12-15 2014-08-27 ティーマ ファウンデーション 組成物およびその使用
EP2612560A1 (fr) 2012-01-09 2013-07-10 N.V. Nutricia Composition nutritionnelle enrichie par glutamine pour les nourrissons prématurés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (fr) * 1985-09-12 1991-07-02 Robert J. Smith Methode de traitement de troubles cataboliques

Also Published As

Publication number Publication date
HUT61193A (en) 1992-12-28
KR0178799B1 (ko) 1999-03-20
DE69031694T2 (de) 1998-03-12
DK0401056T3 (da) 1998-07-27
JP2000186034A (ja) 2000-07-04
HU220214B (hu) 2001-11-28
DE69031694T3 (de) 2007-10-18
JPH05500655A (ja) 1993-02-12
PT94223B (pt) 1997-04-30
JP2000186035A (ja) 2000-07-04
AU641403B2 (en) 1993-09-23
EP0401056A3 (fr) 1991-09-25
EP0401056B1 (fr) 1997-11-12
JP3113877B2 (ja) 2000-12-04
JP2000198733A (ja) 2000-07-18
ES2111529T5 (es) 2007-11-16
EP0401056B2 (fr) 2007-06-13
AU5827190A (en) 1991-01-07
WO1990014823A1 (fr) 1990-12-13
ATE160089T1 (de) 1997-11-15
DK0401056T4 (da) 2007-07-16
IL94549A (en) 1996-08-04
KR920700629A (ko) 1992-08-10
JP3068644B2 (ja) 2000-07-24
ZA904151B (en) 1991-03-27
JP3113878B2 (ja) 2000-12-04
PT94223A (pt) 1991-02-08
NO914730D0 (no) 1991-12-02
DE69031694D1 (de) 1997-12-18
IL94549A0 (en) 1991-03-10
GR3025678T3 (en) 1998-03-31
JP3113876B2 (ja) 2000-12-04
ES2111529T3 (es) 1998-03-16
EP0401056A2 (fr) 1990-12-05

Similar Documents

Publication Publication Date Title
DK0862865T3 (da) Behandling af tobak
AR240255A1 (es) Un metodo de preservacion de virus vivos.
DE69104652D1 (de) Wiederaufschmelzlötofen.
DE68922427D1 (de) Verfahren zur Zurückgewinnung von sauerstoffreichem Gas.
FI915677A0 (fi) Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.
DE3689204D1 (de) Schaltung zur Korrektur von Rasterverzerrungen.
JPS6427474A (en) Plant virus or correction of its effect
IT1133069B (it) Procedimento e dispositivo per l estrazione e trattamento di materie solide da soluzioni o sospensioni particolarmente da acque di macellazione a scopo di ricupero
DE3761253D1 (de) Verfahren zur aufbereitung von kohle.
EP0608212A4 (fr) Procede de traitement des infections virales.
NO902691D0 (no) Kretsanordning for trening og drift av gassutladningslamper.
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
DE69014057D1 (de) Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen.
DE69002558D1 (de) Zusammensetzungen und methoden zur verhinderung von inkrustierungen.
DE69101652D1 (de) Behandlungsofen.
CA2057055A1 (fr) Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote
DK154787A (da) Fremgangsmaade til ekstraktion af paraffiner fra blandinger af paraffiner og alkansulfonsyrer.
DE3787518D1 (de) Hochofenverfahren.
DE3773106D1 (de) Methode zur entschwefelung von rauchgas.
DE3868191D1 (de) Schaltung zur erzeugung einer fernsehbildpunktsynchronisation und ihre anwendung zur einblendung von zeichen.
DE3878137D1 (de) Behandlungsmethode zur bodenstabilisierung.
DE68921485D1 (de) Verfahren zur Rückgewinnung von Abgas einer Kohlefeuerung.
DE68909397D1 (de) Verfahren zur Steigerung des Wachstums von Hefe.
ATE96029T1 (de) Zusammensetzung und verfahren zur behandlung von hepatitisvirusinfektionen unter verwendung von 1(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5- ethyluracil.
IT8723079A0 (it) Cappa per l'aspirazione convogliata di gas e fumi.